Connection

Walter Ageno to Fibrinolytic Agents

Back to Details
This is a "connection" page, showing publications Walter Ageno has written about Fibrinolytic Agents.
Walter Ageno
Connection Strength
0.756
Fibrinolytic Agents
  1. Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance. Expert Opin Pharmacother. 2018 Aug; 19(11):1177-1185.
    View in: PubMed
    Score: 0.321
  2. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
    View in: PubMed
    Score: 0.091
  3. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
    View in: PubMed
    Score: 0.091
  4. A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2. JACC Cardiovasc Interv. 2018 03 12; 11(5):417-434.
    View in: PubMed
    Score: 0.078
  5. Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism. J Clin Epidemiol. 2018 05; 97:1-13.
    View in: PubMed
    Score: 0.077
  6. Clinical conundrums in antithrombotic therapy management: A Delphi Consensus panel. Int J Cardiol. 2017 Dec 15; 249:249-256.
    View in: PubMed
    Score: 0.076
  7. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020 May; 18(3):167-169.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.